Page last updated: 2024-08-23

silybin and deferoxamine

silybin has been researched along with deferoxamine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Bornman, L; Cronjé, L; Edmondson, N; Eisenach, KD1
Amirghofran, Z; Gharagozloo, M; Khoshdel, Z1

Other Studies

3 other study(ies) available for silybin and deferoxamine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Iron and iron chelating agents modulate Mycobacterium tuberculosis growth and monocyte-macrophage viability and effector functions.
    FEMS immunology and medical microbiology, 2005, Aug-01, Volume: 45, Issue:2

    Topics: Base Sequence; Cell Survival; Deferoxamine; DNA, Bacterial; Humans; Iron; Iron Chelating Agents; Macrophages; Monocytes; Mycobacterium tuberculosis; Silybin; Silymarin; U937 Cells

2005
The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: a comparison with desferrioxamine.
    European journal of pharmacology, 2008, Jul-28, Volume: 589, Issue:1-3

    Topics: Antioxidants; Apoptosis; Cell Cycle; Cell Proliferation; Cell Survival; Deferoxamine; DNA Replication; Dose-Response Relationship, Drug; Humans; Iron; Iron Chelating Agents; Jurkat Cells; Leukemia, T-Cell; Silybin; Silymarin; Time Factors

2008